What is the recommended treatment for cat scratch disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Cat Scratch Disease

The recommended first-line treatment for cat scratch disease is azithromycin, with a dosage of 500 mg on day 1 followed by 250 mg for 4 additional days for patients >45 kg, and 10 mg/kg on day 1 and 5 mg/kg for 4 more days for patients <45 kg. 1

Clinical Presentation and Diagnosis

Cat scratch disease (CSD) is caused by Bartonella henselae, typically acquired from infected cats. The clinical presentation includes:

  • Regional lymphadenopathy developing approximately 3 weeks after inoculation
  • Papule or pustule at the scratch/bite site appearing 3-30 days after exposure
  • Extranodal manifestations in approximately 2% of cases
  • Suppurative nodes in about 10% of cases 1

Diagnosis is primarily made through:

  • Serology (note: antibodies may not be detectable for up to 6 weeks post-infection)
  • Histopathology using Warthin-Starry silver stain showing characteristic bacilli
  • PCR for identification and speciation (though not widely accessible) 1

Treatment Algorithm

1. Uncomplicated CSD in Immunocompetent Patients

  • First-line: Azithromycin 500 mg on day 1, then 250 mg daily for 4 days (for patients >45 kg) 1
  • A randomized controlled trial demonstrated that azithromycin treatment resulted in significantly faster resolution of lymphadenopathy compared to placebo within the first 30 days 2
  • Many uncomplicated cases resolve spontaneously without antibiotics 3, 4

2. Alternative Treatment Options

  • Erythromycin 500 mg four times daily for 2 weeks to 2 months 1
  • Doxycycline 100 mg twice daily for 2 weeks to 2 months 1
  • For cat bite/scratch infections (not specifically CSD): Amoxicillin-clavulanate 875/125 mg twice daily 1

3. Special Populations

Immunocompromised Patients:

  • Longer treatment courses (>3 months) are recommended 1
  • Consider combination therapy with azithromycin and rifampicin for disseminated disease 5

CNS Involvement:

  • Doxycycline with or without rifampin is recommended 1

Diabetic Patients:

  • Amoxicillin-clavulanate 875/125 mg orally twice daily for 5-7 days
  • Doxycycline 100 mg twice daily for penicillin-allergic patients 1

Follow-up and Monitoring

  • Schedule follow-up appointments to assess symptom resolution
  • Be aware that lymphadenopathy may persist for 1-6 months despite appropriate treatment
  • Clinical reassessment within 24-48 hours is necessary for patients with worsening lymphangitis and edema 1

Important Clinical Considerations

  1. Atypical Presentations: Up to 25% of cases may present atypically with ocular involvement, encephalopathy, granulomatous hepatitis, hepatosplenic infection, endocarditis, or osteomyelitis 4

  2. Prevention in High-Risk Individuals: Immunocompromised patients should:

    • Avoid rough play with cats
    • Keep cats' nails trimmed
    • Wash hands thoroughly after handling cats
    • Consider avoiding cat ownership or adopt cats over 1 year of age
    • Implement proper flea control for cats 1
  3. Treatment Efficacy: While several antibiotics show in vitro activity against B. henselae, greatest clinical efficacy has been observed with rifampin, ciprofloxacin, gentamicin, trimethoprim-sulfamethoxazole, clarithromycin, and azithromycin 3

  4. Seasonal Variation: Higher rates of infection are reported in autumn and winter in temperate climates, attributed to seasonal breeding of domestic cats 4

References

Guideline

Cat Ownership and Immunocompromised Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of cat-scratch disease.

Current opinion in pediatrics, 2001

Research

Cat-scratch disease: epidemiology, aetiology and treatment.

British journal of biomedical science, 2001

Research

Disseminated cat-scratch disease during abatacept therapy for rheumatoid arthritis in an older patient: A case report and review of the literature.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.